EMA
withdrawal
· 2009-09-23
EMA Application withdrawn: Opaxio — CTI Life Sciences Ltd
Summary
The EMA application for Opaxio by CTI Life Sciences Ltd was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Application withdrawn. Therapeutic area: Carcinoma, Non-Small-Cell Lung. MAH: CTI Life Sciences Ltd. Decision date: 31/12/2009